World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
123
Citations
78694
World Ranking
3282
National Ranking
1808

Overview

K. Rajender Reddy is affiliated with the University of Pennsylvania in the United States and has contributed extensively to the field of medicine, particularly in hepatology. Their research output includes over 500 publications, with a strong focus on liver-related diseases and treatment modalities.

Their recent notable papers feature diverse topics relevant to hepatology and liver transplantation, including:

  • Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement (2020, Hepatology)
  • Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome (2021, New England Journal of Medicine)
  • ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury (2021, The American Journal of Gastroenterology)
  • Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort (2020, Gut)
  • The Evolving Challenge of Infections in Cirrhosis (2021, New England Journal of Medicine)

The scientist frequently collaborates with peers active in hepatology and related fields. Frequent co-authors include:

  • Jasmohan S. Bajaj
  • Patrick S. Kamath
  • Leroy R. Thacker
  • Florence Wong
  • Hugo E. Vargas

Publications by Reddy appear predominantly in the following venues:

  • Journal of Hepatology
  • Gastroenterology
  • Liver Transplantation
  • Hepatology
  • Clinical Gastroenterology and Hepatology

Reddy's primary field of study is Medicine, with a specialization in hepatology encompassing numerous subfields, including:

  • Hepatology
  • Epidemiology
  • Surgery
  • Infectious Diseases
  • Pharmacology

The main topics addressed in their research involve detailed study of liver diseases and transplantation. Specific topics include:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Hepatitis C Virus Research
  • Organ Transplantation Techniques and Outcomes
  • Drug-Induced Hepatotoxicity and Protection
  • Hepatitis B Virus Studies
  • Hepatocellular Carcinoma Treatment and Prognosis

Best Publications

  • Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

    Michael W. Fried;Mitchell L. Shiffman;K. Rajender Reddy;Coleman Smith

  • Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie

  • Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.

    Guadalupe Garcia-Tsao;Arun J. Sanyal;Norman D. Grace;William D. Carey

  • Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection

    Arie Regev;Mariana Berho;Lennox J. Jeffers;Clara Milikowski

  • Sofosbuvir for previously untreated chronic hepatitis C infection

    Eric Lawitz;Alessandra Mangia;David Wyles;Maribel Rodriguez-Torres

  • Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

    Nezam Afdhal;K. Rajender Reddy;David R. Nelson;Eric Lawitz

  • Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection

    Mark S. Sulkowski;David F. Gardiner;Maribel Rodriguez-Torres;K. Rajender Reddy

  • Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

    Kris V. Kowdley;Stuart C. Gordon;K. Rajender Reddy;Lorenzo Rossaro

  • Diagnosis and treatment of hepatocellular carcinoma.

    Hashem B. El-Serag;Jorge A. Marrero;Lenhard Rudolph;K. Rajender Reddy

  • ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

    Peter Ferenci;David Bernstein;Jacob Lalezari;Daniel Cohen

  • Sofosbuvir and velpatasvir for HCV in patients with decompensated cirrhosis

    M. P. Curry;J. G. O'Leary;N. Bzowej;A. J. Muir

  • Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

    Michael Charlton;Gregory T. Everson;Steven L. Flamm;Princy Kumar

  • α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma

    Jorge A. Marrero;Ziding Feng;Yinghui Wang;Mindie H. Nguyen

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy

    Robert P. Perrillo;Robert Gish;Yngve T. Falck-Ytter

  • Sofosbuvir, velpatasvir, and voxilaprevir for previously treated HCV infection

    Marc Bourlière;Stuart C. Gordon;Steven L. Flamm;Curtis L. Cooper

  • Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

    Peter Ferenci;Michael W. Fried;Mitchell L. Shiffman;Coleman I. Smith

  • Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial

    Stefan Zeuzem;Reem Ghalib;K. Rajender Reddy;Paul J. Pockros

  • Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy†‡§

    Donald M. Jensen;Timothy R. Morgan;Patrick Marcellin;Paul J. Pockros

  • Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

    Maria M Bartholomew;Robert W Jansen;Lennox J Jeffers;K Rajender Reddy

Frequent Co-Authors

Florence Wong
Florence Wong University of Toronto
Jasmohan S. Bajaj
Jasmohan S. Bajaj Virginia Commonwealth University
Guadalupe Garcia-Tsao
Guadalupe Garcia-Tsao Yale University
Eugene R. Schiff
Eugene R. Schiff University of Miami
Paul J. Thuluvath
Paul J. Thuluvath Mercy Medical Center
Michael W. Fried
Michael W. Fried University of North Carolina at Chapel Hill
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
Nezam H. Afdhal
Nezam H. Afdhal Beth Israel Deaconess Medical Center
David R. Nelson
David R. Nelson University of Tennessee Health Science Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always require following the traditional MD route. There are a variety of online degrees and career pathways in the healthcare field that offer flexibility, accessibility, and different advancement opportunities. For those interested in administrative work, exploring the best medical billing and coding schools online can lead to in-demand jobs that support hospitals and clinics behind the scenes.

If you’re aiming for a clinical role, many students prefer to start with nursing. Some programs, such as nursing school that does not require teas test, make admissions less daunting. For those interested in leadership, an online healthcare management degree can prepare you for roles in hospital administration, policy, and team leadership.

Already have an associate's degree in nursing? The asn to np bridge programs provide a streamlined path to become a nurse practitioner, expanding your clinical authority and career prospects. These varied pathways allow you to enter or advance in the healthcare industry at your own pace and according to your interests.

Best Scientists Citing K. Rajender Reddy

Trending Scientists